{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T15:05:32Z","timestamp":1649084732538},"reference-count":17,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jcin.2013.10.003","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T17:40:39Z","timestamp":1384364439000},"page":"1282-1283","source":"Crossref","is-referenced-by-count":2,"title":["Drug Interactions With Good Old Clopidogrel"],"prefix":"10.1016","volume":"6","author":[{"given":"Freek W.A.","family":"Verheugt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2013.10.003_bib1","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/eurheartj\/ehp230","article-title":"New antithrombotic agents: are they needed and what can they offer to patients with a non-ST-elevation acute coronary syndrome?","volume":"30","author":"Van de Werf","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2013.10.003_bib2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effect of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2013.10.003_bib3","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2013.10.003_bib4","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2013.10.003_bib5","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2013.10.003_bib6","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(06)68819-3","article-title":"Good old warfarin for stroke prevention in atrial fibrillation","volume":"367","author":"Verheugt","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2013.10.003_bib7","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in\u00a0patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2013.10.003_bib8","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2013.10.003_bib9","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2010.11.024","article-title":"Clopidogrel-drug interactions","volume":"57","author":"Bates","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2013.10.003_bib10","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2013.10.003_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0002-9149(03)00626-X","article-title":"Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies","volume":"92","author":"Wienbergen","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2013.10.003_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ahj.2005.08.023","article-title":"A\u00a0pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention","volume":"152","author":"Brophy","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2013.10.003_bib13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000088780.57432.43","article-title":"Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial","volume":"108","author":"Saw","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2013.10.003_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2007.01.097","article-title":"Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial","volume":"50","author":"Saw","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2013.10.003_bib15","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jacc.2008.07.055","article-title":"Calcium-channel blockers reduce the antiplatelet effect of clopidogrel","volume":"52","author":"Siller-Matula","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2013.10.003_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/hrt.2009.171488","article-title":"Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition","volume":"96","author":"Gremmel","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.jcin.2013.10.003_bib17","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jcin.2013.06.014","volume":"6","author":"Ojeifo","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879813014489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879813014489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T16:22:07Z","timestamp":1539188527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879813014489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1936879813014489"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2013.10.003","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}